DEVELOPMENT OF BIOMARKERS OF MINIMAL RESIDUAL DISEASE IN STAGE II MELANOMA USING DROPLET DIGITAL PCR-BASED ASSAYS TO DETECT CELL-FREE, METHYLATED DNAS IN PLASMA

New York University, New York NY

Investigators